These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of plasma levels of adrenomedullin and ghrelin, and their correlation with electrophysiological changes in diabetic neuropathy. Zakareia FA. Neurosciences (Riyadh); 2012 Oct; 17(4):327-35. PubMed ID: 23022897 [Abstract] [Full Text] [Related]
3. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, soluble fatty acid synthase, and adrenomedullin in diabetic retinopathy. Zakareia FA, Alderees AA, Al Regaiy KA, Alrouq FA. J Diabetes Complications; 2010 Oct; 24(3):179-85. PubMed ID: 19216096 [Abstract] [Full Text] [Related]
4. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W. Przegl Lek; 2007 Oct; 64(6):423-30. PubMed ID: 18159852 [Abstract] [Full Text] [Related]
5. VEGF gene transfer for diabetic neuropathy. Isner JM, Ropper A, Hirst K. Hum Gene Ther; 2001 Aug 10; 12(12):1593-4. PubMed ID: 11529248 [Abstract] [Full Text] [Related]
6. Subclinical peripheral neuropathy in stable middle-aged patients with chronic obstructive pulmonary disease. Agrawal D, Vohra R, Gupta PP, Sood S. Singapore Med J; 2007 Oct 10; 48(10):887-94. PubMed ID: 17909671 [Abstract] [Full Text] [Related]
7. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus. Karsidag S, Morali S, Sargin M, Salman S, Karsidag K, Us O. Diabetes Res Clin Pract; 2005 Mar 10; 67(3):211-9. PubMed ID: 15713353 [Abstract] [Full Text] [Related]
8. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline. Van Brakel WH, Nicholls PG, Das L, Barkataki P, Maddali P, Lockwood DN, Wilder-Smith E. Lepr Rev; 2005 Dec 10; 76(4):277-95. PubMed ID: 16411508 [Abstract] [Full Text] [Related]
9. [Comparison between Dyck's criteria and the polyneuropathy index-revised (PNI-R) in the electrophysiologic evaluation of diabetic neuropathy]. Hasegawa O, Matsumoto S, Gondo G, Wada N, Arita T. No To Shinkei; 2001 Nov 10; 53(11):1015-9. PubMed ID: 11761909 [Abstract] [Full Text] [Related]
10. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients. Uluc K, Isak B, Borucu D, Temucin CM, Cetinkaya Y, Koytak PK, Tanridag T, Us O. Clin Neurophysiol; 2008 Apr 10; 119(4):880-5. PubMed ID: 18291716 [Abstract] [Full Text] [Related]
11. F-ratio, a surrogate marker of carpal tunnel syndrome. Husain A, Omar SA, Habib SS, Al-Drees AM, Hammad D. Neurosciences (Riyadh); 2009 Jan 10; 14(1):19-24. PubMed ID: 21048568 [Abstract] [Full Text] [Related]
12. Sural nerve conduction velocity and refractory period in diabetics without clinical signs of neuropathy. Schütt P, Muche H, Lehmann HJ, Hielscher H. Horm Metab Res Suppl; 1980 Jan 10; 9():39-42. PubMed ID: 6929776 [Abstract] [Full Text] [Related]
13. Nerve conduction study of healthy Asian Malays: the influence of age on median, ulnar, and sural nerves. Awang MS, Abdullah JM, Abdullah MR, Tahir A, Tharakan J, Prasad A, Razak SA. Med Sci Monit; 2007 Jul 10; 13(7):CR330-2. PubMed ID: 17599028 [Abstract] [Full Text] [Related]
14. [Interrelationship among nerve conduction velocity, amplitudes of compound muscle and compound nerve action potentials in diabetic neuropathy]. Hasegawa O, Matsumoto S, Iino M, Mori I, Arita T, Baba Y. No To Shinkei; 1999 Oct 10; 51(10):863-6. PubMed ID: 10553586 [Abstract] [Full Text] [Related]
15. The use of F-wave and sural potential in the diagnosis of subclincal diabetic neuropathy in Saudi patients. Ahmed TS, Mekki MO, Kabiraj MM, Reza HK. Neurosciences (Riyadh); 2001 Jul 10; 6(3):169-74. PubMed ID: 24185364 [Abstract] [Full Text] [Related]
16. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Nicolucci A, Carinci F, Cavaliere D, Scorpiglione N, Belfiglio M, Labbrozzi D, Mari E, Benedetti MM, Tognoni G, Liberati A. Diabet Med; 1996 Dec 10; 13(12):1017-26. PubMed ID: 8973882 [Abstract] [Full Text] [Related]
17. Sensory nerve conduction in diabetes mellitus and diabetic neuropathy. Sathiamoorthy A, Reddy LP, Sathiamoorthy SS, Balachander J, Chandrasekar S. Indian J Physiol Pharmacol; 1983 Dec 10; 27(2):118-22. PubMed ID: 6885123 [Abstract] [Full Text] [Related]
18. Peripheral nerve changes assessed by conduction velocity distribution in patients with primary Raynaud's phenomenon and dysautonomia. Koszewicz M, Gosk-Bierska I, Jerzy G, Bilińska M, Podemski R, Budrewicz S, Adamiec R. Int Angiol; 2011 Aug 10; 30(4):375-9. PubMed ID: 21747356 [Abstract] [Full Text] [Related]
19. Possible contribution of adipocytokines on diabetic neuropathy. Matsuda M, Kawasaki F, Inoue H, Kanda Y, Yamada K, Harada Y, Saito M, Eto M, Matsuki M, Kaku K. Diabetes Res Clin Pract; 2004 Dec 10; 66 Suppl 1():S121-3. PubMed ID: 15563961 [Abstract] [Full Text] [Related]
20. [Polyneuropathy index-revised in the evaluation of diabetic neuropathy]. Hasegawa O, Matsumoto S, Gondo G, Arita T. No To Shinkei; 2001 Mar 10; 53(3):259-63. PubMed ID: 11296400 [Abstract] [Full Text] [Related] Page: [Next] [New Search]